Method for producing compound containing heterocycle

1. A method for producing a compound having a heterocycle introduced by an azoline backbone introducing enzyme comprising:

preparing a peptide represented by the following formula (I):

(Xaa 2 )m-(Xaa 3 )n-(Xaa 4 )o  (I)

wherein,

(Xaa 2 )m represents m numbers of arbitrary amino acids and m represents an integer selected from 0 to 10;

(Xaa 3 )n represents n numbers of arbitrary amino acids, at least one of which is an amino acid selected from the group consisting of Cys, Ser, Thr, 2,3-diamino acids, homocysteine, homoserine, and 2,4-diamino acids, and analogs thereof, and n represents an integer selected from 2 to 40; and

(Xaa 4 )o represents o numbers of arbitrary amino acids and o represents an integer selected from 0 to 10, and

reacting the peptide with an azoline backbone introducing enzyme to which a leader sequence of a substrate or a partial sequence thereof has been bound to introduce a heterocycle into at least one of Cys, Ser, Thr, 2,3-diamino acids, homocysteine, homoserine, and 2,4-diamino acids, and analogs thereof of (Xaa 3 )n,

wherein the leader sequence of a substrate or the partial sequence thereof has been bound to the N terminal of the azoline backbone introducing enzyme.

2. The method according to claim 1 , wherein the leader sequence or the partial sequence thereof has the following sequence:

MNKKNILPQQGQPVIRLTAGQLSSQLAELSEEALGDA (SEQ ID NO: 1)

MKEQNSFNLLQEVTESELDLILGA(SEQ ID NO: 2)

MILASLSTFQQMWISKQEYDEAGDA(SEQ ID NO: 3)

MELQLRPSGLEKKQAPISELNIAQTQGGDSQVLALNA (SEQ ID NO: 4); or a partial sequence thereof.

3. The method according to claim 1 , wherein the leader sequence has been bound to the azoline backbone introducing enzyme via a spacer.

4. The method according to claim 1 , wherein the (Xaa 3 )n is (Xaa 5 Xaa6)p

wherein, p numbers of Xaa 5 each independently represent an arbitrary amino acid, p numbers of Xaa 6 each independently represent an amino acid selected from the group consisting of Cys, Ser, Thr, 2,3-diamino acids, homocysteine, homoserine, and 2,4-diamino acids, and analogs thereof, and p is selected from 1 to 20.

5. The method according to claim 4 , wherein the Xaa 6 is Cys.

6. The method according to claim 1 , wherein the (Xaa 4 )o contains, at the N terminal thereof, Ala-Tyr-Asp.

7. The method according to claim 1 , wherein the step of preparing a peptide represented by the formula (I) comprises:

preparing a nucleic acid encoding the peptide represented by the formula (I), and

translating the nucleic acid in a cell-free translation system.

8. The method according to claim 1 , wherein the peptide represented by the formula (I) contains an amino acid used for cyclization.

9. A method for producing a compound having a heterocycle introduced by an azoline backbone introducing enzyme comprising:

preparing a peptide represented by the following formula (I):

(Xaa 2 )m-(Xaa 3 )n-(Xaa 4 )o  (I)

wherein

(Xaa 2 )m represents m numbers of arbitrary amino acids and m represents an integer selected from 0 to 10;

(Xaa 3 )n represents n numbers of arbitrary amino acids, at least one of which is an amino acid selected from the group consisting of Cys, Ser, Thr, 2,3-diamino acids, homocysteine, homoserine, and 2,4-diamino acids, and analogs thereof, and n represents an integer selected from 2 to 40; and

(Xaa 4 )o represents o numbers of arbitrary amino acids and o represents an integer selected from 0 to 10, and

reacting the peptide with an azoline backbone introducing enzyme to which a leader sequence of a substrate or a partial sequence thereof has been bound to introduce a heterocycle into at least one of Cys, Ser, Thr, 2,3-diamino acids, homocysteine, homoserine, and 2,4-diamino acids, and analogs thereof of (Xaa 3 )n,

wherein the peptide represented by the formula (I) contains an amino acid used for cyclization,

wherein the peptide represented by the formula (I) contains an amino acid having any of functional groups belonging to the following Functional group 1 and an amino acid having a functional group corresponding thereto in the following Functional group 2 :

TABLE 1

Functional group 1

Functional group 2

(A)

HS— (A-2)

(B)

—C≡C—H (B-1)

N 3 — (B-2)

(C)

—Ar—CH 2 NH 2 (C-1)

(D)

—C≡C—CH 2 —X 1 (D-1)

HS— (D-2)

(E)

—Ar—CH 2 —X 1 (E-1)

HS— (E-2)

wherein, X 1 represents Cl, Br, or I and Ar represents a substituted or unsubstituted aromatic ring.

10. The method according to claim 1 , further comprising, after the step of introducing a heterocycle, cyclizing the heterocycle-containing compound.

11. A method for producing a compound containing a heterocycle introduced by an azole backbone introducing enzyme, comprising after the step of introducing a heterocycle in the method as claimed in claim 1

reacting the peptide having a heterocycle introduced therein with the azole backbone introducing enzyme and thereby converting at least one of the heterocycles introduced by the azoline backbone introducing enzyme into a heterocycle introduced by the azole backbone introducing enzyme.

12. A method of constructing a library including two or more compounds containing a heterocycle introduced by an azoline backbone introducing enzyme, comprising:

in step of preparing a peptide in the method as claimed in claim 1 , preparing a peptide library including two or more peptides represented by the formula (I) but different in (Xaa 3 )n and, in the step of introducing a heterocycle by an azoline backbone introducing enzyme in the above-described method, introducing the heterocycle in the peptide library,

wherein the step of preparing a peptide library comprises constructing a nucleic acid library encoding the peptide library and translating the nucleic acid library in a cell-free translation system to construct the peptide library.

13. A method of constructing a library including two or more compounds containing a heterocycle introduced by an azoline backbone introducing enzyme, comprising:

in step of preparing a peptide in the method as claimed in claim 1 , preparing a peptide library including a complex of two or more peptides represented by the formula (I) but different in (Xaa 3 )n and mRNAs encoding the peptides, and in the step of introducing a heterocycle by an azoline backbone introducing enzyme in the above-described method, introducing the heterocycle in the peptide library,

wherein the step of preparing a peptide library comprises constructing an mRNA library encoding the peptide library, binding puromycin to the 3′ end of each of the mRNAs to construct a puromycin-bound mRNA library, and translating the puromycin-bound mRNA library in a cell-free translation system to construct a peptide-mRNA complex library.

14. A method of constructing a library including two or more compounds containing a heterocycle introduced by an azole backbone introducing enzyme, comprising:

constructing a library including two or more compounds containing a heterocycle introduced by an azoline backbone introducing enzyme by the method as claimed in claim 12 , and

reacting the library with the azole backbone introducing enzyme to convert at least one of the heterocycles introduced by the azoline backbone introducing enzyme into a heterocycle introduced by the azole backbone introducing enzyme.

15. A screening method for identifying a compound containing a heterocycle that binds to a target substance, comprising:

bringing a compound library constructed by the method as claimed claim 12 into contact with the target substance, and then incubating, and

selecting the compound that has bound to the target substance.

16. A method of constructing a library including two or more compounds containing a heterocycle introduced by an azole backbone introducing enzyme, comprising:

constructing a library including two or more compounds containing a heterocycle introduced by an azoline backbone introducing enzyme by the method as claimed in claim 13 , and

reacting the library with the azole backbone introducing enzyme to convert at least one of the heterocycles introduced by the azoline backbone introducing enzyme into a heterocycle introduced by the azole backbone introducing enzyme.

17. A screening method for identifying a compound containing a heterocycle that binds to a target substance, comprising:

bringing a compound library constructed by the method as claimed in claim 13 into contact with the target substance, and then incubating, and

selecting the compound that has bound to the target substance.

18. A screening method for identifying a compound containing a heterocycle that binds to a target substance, comprising:

bringing a compound library constructed by the method as claimed in claim 14 into contact with the target substance, and then incubating, and

selecting the compound that has bound to the target substance.

19. The method according to claim 9 , wherein the leader sequence of a substrate or the partial sequence thereof has been bound to the N terminal of the azoline backbone introducing enzyme.

20. The method according to claim 9 , wherein the leader sequence or the partial sequence thereof has the following sequence:

MNKKNILPQQGQPVIRLTAGQLSSQLAELSEEALGDA (SEQ ID NO: 1)

MKEQNSFNLLQEVTESELDLILGA(SEQ ID NO: 2)

MILASLSTFQQMWISKQEYDEAGDA(SEQ ID NO: 3)

MELQLRPSGLEKKQAPISELNIAQTQGGDSQVLALNA (SEQ ID NO: 4); or a partial sequence thereof.

21. The method according to claim 9 , wherein the leader sequence has been bound to the azoline backbone introducing enzyme via a spacer.

22. The method according to claim 9 , wherein the (Xaa 3 )n is (Xaa 5 Xaa 6 )p

wherein, p numbers of Xaa 5 each independently represent an arbitrary amino acid, p numbers of Xaa 6 each independently represent an amino acid selected from the group consisting of Cys, Ser, Thr, 2,3-diamino acids, homocysteine, homoserine, and 2,4-diamino acids, and analogs thereof, and p is selected from 1 to 20.

23. The method according to claim 22 , wherein the Xaa 6 is Cys.

24. The method according to claim 9 , wherein the (Xaa 4 )o contains, at the N terminal thereof, Ala-Tyr-Asp.

25. The method according to claim 9 , wherein the step of preparing a peptide represented by the formula (I) comprises:

preparing a nucleic acid encoding the peptide represented by the formula (I), and

translating the nucleic acid in a cell-free translation system.